FDA Panel Convenes to Rule on Seven Peptides as Consumer Demand Holds Firm
The FDA’s Pharmacy Compounding Advisory Committee meets July 23 and 24 to decide whether seven peptides qualify for the agency’s 503A Bulks List — a designation that would permit state-licensed compounding pharmacies to prepare the compounds for patients holding valid prescriptions. The meeting arrives at a moment of sustained consumer pressure, with social media communities, […]
FDA Panel Convenes to Rule on Seven Peptides as Consumer Demand Holds Firm Read More »